investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Validating Syk as a Target for AML Therapy

Kimberly Stegmaier

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Dongsu Park

Role of osteogenic stem cells in bone regeneration and repair in vivo

Leukaemia

James Y. Chen

Clonal Evolution and Prospective Isolation of Myelodysplastic Syndrome Initiating

Leukaemia

Charles G Mullighan

Functional analysis of leukemic CREBBP mutations

Leukaemia

Pediatric oncology or childhood cancer

Derek B. Sant'Angelo

Control of cytokine production by human NK cells

Leukaemia

M. James You

CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF

Leukaemia

Luca Gattinoni

Programming T Cell Fates for Therapeutic Use

Leukaemia

Pathology Hematology and hematologic malignancies

Neil Osheroff

Function and Biology of Eukaryotic DNA Topoisomerases

Leukaemia

Charalampos Kalodimos

Mechanisms of autoinhibition and activation of the Abl kinase

Leukaemia

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Leukaemia

Sign Up For Updates

Stay up to date with what's going on with The GO Map.